Screen Time and Sleep: What the Research Actually Shows

Blue light is not the villain. That finding, buried inside a 2023 meta-analysis published in Sleep Medicine Reviews, cuts against a decade of public health messaging that has blamed smartphone screens almost exclusively for the sleep crisis now documented across urban Brazil. The truth is messier, more behavioral than biological — and for anyone living the high-stimulation lifestyle of Rio de Janeiro, it matters a great deal.

Hormone research published earlier this year reignited wider public interest in how the body regulates melatonin — the hormone that cues the brain toward sleep. Clinicians and wellness coaches from Ipanema to São Cristóvão have fielded a surge of questions about melatonin supplements and screen exposure since mid-2026. The Instituto do Sono, a sleep medicine body with a unit in Botafogo, reported a 34 percent rise in first consultations in the first quarter of this year compared to the same period in 2025, a figure the organization attributes partly to post-pandemic lifestyle recalibration and partly to social media anxiety about sleep quality itself.

What the Research Actually Says

The blue-light hypothesis holds that the short-wavelength light emitted by phone and tablet screens suppresses melatonin production, pushing bedtime later. It is real. But the effect, according to controlled trials including work from Oxford's Sleep and Circadian Neuroscience Institute, is modest — roughly a 1.5-minute delay in melatonin onset per hour of exposure under typical domestic lighting conditions. That is far smaller than the hour-plus delay that chronic late-night scrollers typically experience.

The bigger driver, researchers now argue, is cognitive and emotional arousal. Checking news feeds, replying to WhatsApp messages, watching short-form video — all of it activates the brain's alerting systems regardless of the light wavelength involved. A 2024 study from the Universidade Federal do Rio de Janeiro tracked 412 university students across campuses in Cidade Universitária and found that screen content type was a stronger predictor of sleep latency than screen duration. Students who spent the final 45 minutes before bed on passive, low-stimulation content — streaming calm video, reading long-form text — fell asleep an average of 22 minutes faster than those consuming social media feeds, even when total screen time was identical.

Rio compounds this. The city's outdoor social culture runs late by international standards, with dinner rarely beginning before 9 p.m. in neighborhoods like Leblon and Jardim Botânico. The Fundação Oswaldo Cruz, whose public health research arm operates from the Manguinhos campus in the North Zone, has documented average sleep onset times of 12:47 a.m. among working-age Rio residents — nearly 90 minutes later than the national median for smaller Brazilian cities. Screens are part of that story. But so are noise, heat, and the structural rhythms of a city that treats midnight as early.

Practical Adjustments for the Carioca Routine

The evidence does not support ditching your phone. It supports changing how you use it in the two hours before sleep. Sleep specialists associated with Hospital Copa Star in Copacabana, which runs an outpatient sleep clinic, advise patients to shift the content — not necessarily the device — after 10 p.m. That means turning off push notifications, setting WhatsApp to silent, and switching from algorithmically driven feeds to something lower-stakes: a podcast, an e-reader app, ambient music.

Blue-light filter settings, available on virtually every Android and iOS device since 2017, do carry some marginal benefit, particularly for people who are biologically sensitive to light cues. They cost nothing to activate. But treating them as a complete solution is the mistake. The UFRJ data suggests behavioral change — specifically, choosing calmer content — delivers roughly four times the sleep-latency benefit of blue-light filters alone.

Melatonin supplements, sold over the counter at pharmacies including Ultrafarma branches throughout the Zona Sul, remain contentious among specialists. The current clinical consensus favors low doses of 0.5mg to 1mg taken 90 minutes before the target sleep time, rather than the 5mg to 10mg doses commonly sold. Anyone considering hormone support of any kind should consult a physician rather than rely on social media advice — a point Rio's sleep clinics repeat often, and one the data keeps underscoring.